找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Kinesins and Cancer; Frank Kozielski, FSB Book 2015 Springer Science+Business Media Dordrecht 2015 Cancer chemotherapy.Human mitotic kines

[复制链接]
楼主: commotion
发表于 2025-3-26 22:04:35 | 显示全部楼层
Kinesin-13 Microtubule Depolymerizing Proteins as Targets for Cancer Therapy,rly effective targets for drug development. This chapter reviews the activities of kinesin-13 proteins in the context of how they might be manipulated to affect spindle structure and advance cancer treatment by direct targeting, by enhancing the effectiveness of other current treatments, or by reversing resistance to other treatments.
发表于 2025-3-27 04:31:16 | 显示全部楼层
发表于 2025-3-27 07:38:35 | 显示全部楼层
evance of kinesins to cancer treatment.Contributes to potent.This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting t
发表于 2025-3-27 11:08:14 | 显示全部楼层
发表于 2025-3-27 15:11:05 | 显示全部楼层
Kif15: A Useful Target for Anti-cancer Therapy?, to the central player in mediating Eg5-independent bipolar spindle assembly. In this chapter, we describe the function of Kif15 during mitosis and discuss if Kif15 could be a target for drug development in anticancer therapy.
发表于 2025-3-27 20:30:17 | 显示全部楼层
Kinesin-8 Members and Their Potential as Biomarker or Therapeutic Target, the increased abundance may reflect a higher percentage of proliferative cells. Reduction of Kinesin-8 delays cells in mitosis and perturbs microtubule dynamics. Inhibitors of Kinesin-8 may therefore influence the proliferative capacity or may impair the migratory potential of cancer cells. These ideas remain to be tested.
发表于 2025-3-27 23:06:25 | 显示全部楼层
Clinical Trials of Mitotic Kinesin Inhibitors,nd less toxic inhibitors of the mitotic process. In this chapter, I review the clinical experience with one group of inhibitors that target mitotic kinesins. I will discuss the results of phase I and II trials with these drugs and place the results of these trials in a context to explain how they can be utilized in future human studies.
发表于 2025-3-28 02:36:51 | 显示全部楼层
发表于 2025-3-28 08:16:01 | 显示全部楼层
发表于 2025-3-28 11:14:09 | 显示全部楼层
978-94-024-0365-7Springer Science+Business Media Dordrecht 2015
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 16:23
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表